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Abstract
Purpose: Dual energy computed tomography (DECT) is a new method of computed tomography (CT) imaging, 
allowing the assessment of not only the object’s morphology, but also its composition. The aim of the study was to 
evaluate the potential of in vitro DECT evaluation of urinary stones’ chemical composition.
Material and methods: Six samples of surgically removed renal stones were scanned using DECT and analyzed by 
scanner vendor software. Uric acid stones were marked red and calcium stones white by the software. The real com-
position of the stones was finally verified using physicochemical laboratory analysis.
Results: In 5 out of 6 samples, the composition of stones in DECT (3 samples identified as uric acid and 2 samples as 
calcium) was consistent with the physicochemical analysis (3 samples identified as uric acid, 1 as calcium phosphate, 
1 as calcium oxalate). In DECT it was not possible to determine more precisely the type of calcium compounds 
(calcium phosphate vs. calcium oxalate) as established in the physicochemical analysis.
In one stone identified in physicochemical analysis as uric acid, DECT detected a composite layered structure con-
taining both uric acid and calcium compounds.
Conclusions: DECT allows uric acid to be distinguished from calcium urinary tract stones, which is crucial in the 
choice of appropriate therapy. Using the available hardware and software, it was not possible to more accurately 
distinguish types of calcified stones. Evaluation of the stone type in DECT may be limited in the case of mixed 
chemical composition.
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Introduction
Urolithiasis is a common disease associated with the pres-
ence of insoluble deposits in the urinary tract, which arise 
as a result of the precipitation of chemicals in the urine, 
when their concentration exceeds the solubility thresh-
old. Kidney stones are found in 10-12% of men and about 
5-6% of women throughout life [1]. Deposits can arise 
in various sections of the urinary tract, most common-
ly in the calyces and renal pelvis, and then move to the 
ureter or bladder where they can grow or be excreted in 
the urine.
Sometimes the deposits reach a considerable size, and 
fill the entire renal pelvis and calyces (staghorn calculi), 
leading to kidney damage.
The most common deposits are composed of calci-
um oxalate, less frequently calcium phosphate, including 
calcium phosphate dihydrate (brushite), uric acid, mag-
nesium ammonium phosphate (struvite) and cystine. In 
special cases, other types of urinary stones arise: xanthine 
Monika Stępień, Robert Chrzan, Wojciech Gawlas  
e422 © Pol J Radiol 2018; 83: e421-e425
deposits (in inherited deficiency of xanthine oxidase), acid 
ammonium urate (in chronic diarrhea and hypokalemia), 
oxypurinol and xanthine (in chronic treatment with allop-
urinol or triamterene) [2].
Treatment of urolithiasis depends on the chemical 
composition, location and size of the deposits and may 
be conservative or surgical. Knowledge of the chemical 
composition may be crucial in choosing the right therapy 
and in forecasting the treatment results.
Chemolysis of deposits is possible only in some types 
of nephrolithiasis.
In the case of struvite, brushite, cystine and uric acid 
deposits, percutaneous rinsing with solubilizing agents 
(hemiacridrin, Suby’s G, THAM, N-acetylcysteine) may 
be used.
For uric acid deposits, oral medications may also be ef-
fective to alkalinize the urine to pH of 6.5-7.2 using alkaline 
citrates or sodium bicarbonate; invasive treatment is im-
plemented only when conservative treatment is ineffective.
Cystine deposits are best dissolved at pH = 7.0-7.5 us-
ing mainly D-penicillamine, alpha-MPG, captopril and 
tiopronin [3].
The most common method of urolithiasis treatment 
is lithotripsy with shock waves generated extracorporeal-
ly (extracorporeal shock wave lithotripsy – ESWL). This 
method uses electromagnetic, electrohydraulic or piezo-
electric lithotripters, locating the stone with fluoroscopy 
and/or ultrasound. The optimal location for ESWL is the 
pelvis and calyces (especially upper and middle) and the 
proximal part of the ureter (above the sacroiliac joint line); 
in the distal part of the ureter, it is better to perform ure-
teroscopy. Usually ESWL is used in kidney deposits up to 
20 mm in size and ureter deposits up to 10 mm [3]. Calci-
um oxalate and uric acid stones disintegrate relatively easi-
ly. Calcium phosphates, especially those containing brush-
ite, crumble worse and cystine deposits definitely badly [4].
Other methods of treatment include: ureterorenosco-
py (URS) involving removal of ureter stones under visual 
control using a ureterorenoscope and percutaneous neph-
rolithotomy (PCNL) based on removal of the deposit from 
the kidney or upper ureter, whole or crushed, using an en-
doscope inserted directly into the pelvico-calyceal system.
Determination of the chemical composition of ureter-
al concrements in vivo could significantly influence the 
selection of optimal therapeutic treatment.
Until recently, we did not have a diagnostic method to 
obtain such data before spontaneous expelling or surgical 
removal of concrement.
This situation changed only after the introduction of 
dual energy computed tomography (DECT).
The aim of DECT is to obtain two sets of data (im-
ages) during the acquisition of the same anatomical area 
at different values of X-ray energy (usually 80 keV and 
140 keV) [5].
The theoretical principles of DECT were developed in 
the 1970s, but the first computed tomography scanners 
with the practical implementation of this method, using 
various technical solutions, appeared only a few years ago.
DECT allows deposits containing uric acid to be dis-
tinguished from deposits which do not contain uric acid, 
in tests performed both in vivo and in vitro [6]. Due to 
the different chemical structure, uric acid deposits show 
higher radiodensity Hounsfield unit values using high-en-
ergy radiation (at higher kilovoltage), while other types 
of deposits (including calcium deposits) show higher ra-
diodensity Hounsfield unit values using low-energy ra-
diation (low kilovoltage) [7]. Data obtained in DECT are 
postprocessed using dedicated software, in which voxels 
containing uric acid are coded in a different color com-
pared to voxels that do not contain uric acid.
The assessment of the usefulness of DECT in determin-
ing the chemical composition of urinary stones is an in-
creasingly common subject of research [7-11]. Most of them 
are in vivo studies, but some focus on in vitro evaluation.
The aim of our study was to evaluate the possibilities 
of in vitro DECT assessment of urinary stones’ chemical 
composition.
Material and methods
Six samples of surgically removed urinary stones were 
analyzed. The individual samples were placed in closed 
plastic containers. There were both single large and nu-
merous small concrements within the samples.
The samples were scanned in the DECT technique us-
ing a Toshiba Aquilion Prime 80 computed tomography 
scanner, with the following parameters: voltage and cur-
rent 135 kV and 100 mA or 80 kV and 570 mA, rotation 
time 0.5 s, configuration of detectors 80 × 0.5 mm, pitch 
0.171, reconstruction interval and slice thickness 1 mm, 
FOV (field of view) 65 mm.
The CTDIvol (CT dose index) for the above protocol 
was 33.2 mGy.
After processing the data from scanning in the DECT 
technique, the axial images and the secondary 2D and 3D 
reconstructions were obtained.
The analysis of the above images was performed using 
Toshiba DE Stone Analysis software.
The elements of samples containing uric acid were 
marked by the program in red, while those containing cal-
cium compounds were marked in white (Figures 1 and 2).
The composition of stone samples determined in the 
above way was compared with their composition evaluated 
in the laboratory tests during physico-chemical analysis.
Results
After DECT examination of six samples and data process-
ing, axial images and secondary 2D and 3D reconstruc-
tions were obtained, with elements containing uric acid 
marked in red, and those containing calcium compounds 
in white (Figures 1-8).
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In five out of six samples (Figures 3-7) the assess-
ment of the stones’ composition in DECT (three sam-
ples determined as uric acid and two samples as calcium 
compounds) agreed with the result of physico-chemical 
analysis (three samples defined as uric acid, one as calci-
um phosphate, one as calcium oxalate). In DECT tech-
nique, it was not possible to determine more precisely 
the type of calcium compounds (calcium phosphate vs. 
calcium oxalate), as verified in the physico-chemical 
study.
In one of the six samples (Figure 8), the stone deter-
mined in the physico-chemical analysis as a uric acid de-
posit, in DECT turned out to have a complex layered struc-
ture, containing both uric acid and calcium compounds.
Discussion
Commonly available multi-row CT allows the assessment 
of only the size and location of stones. Due to the over-
lapping ranges of CT attenuation values among different 
types of calculi, it is impossible to determine their chem-
ical composition in a typical CT scan [12].
The introduction of the DECT method changed it – 
dual energy computed tomography allows one to differ-
Figure 1. DECT – 6 samples of surgically removed urinary stones – 2D re-
construction in the sagittal plane; respectively from above: uric acid, calcium 
oxalate, uric acid, uric acid, calcium phosphate, layered stone containing 
both uric acid and calcium compounds; uric acid marked in red, calcium 
compounds in white
Figure 3. DECT – a sample of surgically removed urinary stone – axial cross 
section – uric acid
Figure 2. DECT – 6 samples of surgically removed urinary stones – 3D re-
construction; respectively from above: uric acid, calcium oxalate, uric acid, 
uric acid, calcium phosphate, layered stone containing both uric acid and 
calcium compounds; uric acid marked in red, calcium compounds in white
Figure 4. DECT – a sample of surgically removed urinary stone – axial cross 
section – calcium oxalate
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entiate with high accuracy uric acid from non-uric acid 
stones, both in vivo [7, 8] and in vitro [9-11].
Our in vitro DECT study of the stones’ composition, 
with analysis performed by the scanner manufacturer’s 
software, confirmed the possibility of distinguishing uric 
acid from calcium-containing concrements; however, it 
was not possible to determine more precisely the type of 
calcium compounds.
Similarly, Graser et al. [9] found that in DECT it is possi-
ble to reliably distinguish between uric acid and other types 
of stones, but the range of attenuation values for struvite 
stones largely overlapped with the range for mixed stones 
and partially with the range for calcified concrements.
According to data from the literature, more groups of 
deposits can be distinguished by means of more advanced 
software and modification of the beam filtration.
Hidas et al. [8], in a study using a CT scanner with 
a single x-ray tube and a dual array of high and low energy 
photon detectors, assessed the urinary stones in patients 
in vivo preoperatively and compared the results with post-
operative X-ray diffraction analysis of the stones.
Before in vivo CT scanning, the researchers created 
a catalog of stones with known chemical composition, in 
which they assigned deposits to seven groups (including 
uric acid, cystine, struvite, apatite, weddellite, whew-
ellite and brushite) and then they evaluated the ratio of 
low-energy attenuation to high-energy attenuation for 
every above-mentioned stone. Using data obtained from 
an in vitro CT study, researchers were able to distinguish 
between uric acid, cystine and calcium stones, in a CT 
study performed in vivo. Due to some similarity of chem-
ical structure, technical limitations of the CT scanner 
Figure 8. DECT – a sample of surgically removed urinary stone – axial cross 
section – layered concrement containing both uric acid and calcium compounds
Figure 5. DECT – a sample of surgically removed urinary stone – axial cross 
section – uric acid
Figure 6. DECT – a sample of surgically removed urinary stone – axial cross 
section – uric acid
Figure 7. DECT – a sample of surgically removed urinary stone – axial cross 
section – calcium phosphate
 In vitro analysis of urinary stone composition in dual-energy computed tomography 
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and differences in radiation beam absorption in patients 
with different body structures, it was not possible to dis-
tinguish between struvite stones and subtypes of calcium 
deposits.
Fung et al. [10], using a dual-source CT scanner with 
a tin filter attached to the X-ray tube emitting high-energy 
radiation, were able to differentiate in vitro stones contain-
ing uric acid, calcium oxalates and calcium phosphates. 
Application of a tin filter resulted in better separation of 
the attenuation values of oxalates and calcium phosphates, 
enabling their differentiation.
Similarly, Qu et al. [11] evaluated the composition 
of stones in vitro, using a dual energy, dual-source CT 
scanner with an additional tin filter. In this study it was 
possible to distinguish five groups of concrements: (group 
1: uric acid, uric acid dihydrate, ammonium acid urate; 
group 2: cystine; group 3: struvite; group 4: calcium ox-
alate monohydrate, calcium oxalate dihydrate, brushite; 
group 5: hydroxyapatite and carbonate apatite). However, 
the authors noted partial overlap of the features of some 
concrement types. Moreover, the additional tin filter is an 
option available only from some manufacturers.
In our dual energy CT study, in most cases the assess-
ment of the chemical composition of stones agreed with 
the result of the physico-chemical analysis (uric acid vs. 
calcium deposits); in one case, however, we found dis-
cordance. The reason was a mixed-layered structure of 
the stone, built of both uric acid and calcium compounds.
Similarly, Manglaviti et al. [7], investigating the con-
crements with a dual-source CT apparatus, in four cases 
found a discrepancy between the CT assessment of the 
chemical composition of concrements and the result of 
the crystallographic study. All the erroneously evaluated 
concrements had a mixed chemical structure (they con-
tained uric acid and hydroxyapatite) and had a diameter 
below 1 cm. Probably the mixed chemical structure of the 
concrement, combined with its small size, contribute to 
the accuracy reduction in the DECT technique analysis.
Our study concerned the use of DECT technique to 
assess urinary stone composition in vitro, whereas in the 
case of such in vivo assessment, the radiation dose used 
during the study becomes an important factor. The com-
puted tomography dose index (CTDIvol) for our protocol 
was 33.2 mGy, which is a significantly higher value than 
that used in standard abdominal and pelvic examinations 
(about 7-18 mGy) and much higher than the value in the 
dedicated low-dose protocol for the assessment of urinary 
tract stones (approx. 4 mGy). Fortunately, in the case of in 
vivo evaluation, the DECT protocol with the higher dose 
is used only in the range including the location of the con-
crements. Moreover, Chaytor et al. [13] found that reliable 
in vivo DECT assessment of stone composition is possible 
using a lower CTDIvol value of 11.7 mGy.
Conclusions
1.  Dual-energy CT technique enables differentiation of 
uric acid from calcium-containing urinary stones.
2.  Using the available hardware and software, more detailed 
distinction of calcified stone subtypes was not possible.
3.  Evaluation of urinary stones’ chemical composition 
in dual-energy computed tomography may be limited 
in the case of concrements with mixed chemical com-
position.
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